Trial Profile
Should Salmeterol/Fluticasone Propionate (Sal/Fp) be Added to Routine Copd Treatment with Fenoterol/ Ipratropium Bromide (Fen/Ib) - Pharmacoeconomic Assessment of Copd Treatment Based on Observational Research (Phactor)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fenoterol/ipratropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 21 Jan 2011 New trial record